Recent advances in primary resistance mechanisms against immune checkpoint inhibitors

The resistance of immune checkpoint inhibitors (ICIs) has become an obstacle to further improve the survival of patients with advanced cancer. This review provides an overview of recent advances in primary resistance mechanisms of ICIs. RECENT FINDINGS: With the improvement of study approach, new ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yi-Ze, Zhang, Hong-Mei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
LUNG AND MEDIASTINUM: Edited by Robert Pirker and Caicun Zhou
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8654244/
https://www.ncbi.nlm.nih.gov/pubmed/34669646
http://dx.doi.org/10.1097/CCO.0000000000000802

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8654244/
https://www.ncbi.nlm.nih.gov/pubmed/34669646
http://dx.doi.org/10.1097/CCO.0000000000000802

Ejemplares similares